Services

Choose from ready-to-use products or get customized solutions for your technology or workflow.

Custom Assay Development Services

We offer end-to-end development and optimization of allele-specific assays using our proprietary Switch-Blocker™ chemistry, tailored to your genomic targets and sample types.

Services include:

Assay design and validation (SNPs, indels, CNVs)
Multiplex panel development
Custom primer/blocker synthesis
Compatibility testing with user-supplied instruments
Protocol development and optimization
Analytical performance benchmarking (LOD, linearity, specificity)

Deliverables:

Custom assay reagents (blockers, primers)
Detailed protocol and qPCR conditions
Validation report (LOD, specificity, amplification profiles)
Final assay transfer package (documentation, support)

Typical Turnaround Times:

Feasibility & design: 1–2 weeks
Synthesis & initial validation: 4 weeks
Optimization & reporting: 3-4 weeks
Full project timeline: ~8–10 weeks (dependent on complexity)

Project Management and Collaboration

Our collaborative development process ensures alignment, transparency, and technical success at each phase. We work closely with your team from design through delivery, maintaining high scientific standards and open communication.

Our Responsibilities:

Dedicated project lead and assay design scientist
Clear milestone tracking and weekly updates
Data-driven decisions with shared validation results
Confidential handling of target sequences and sample data

Collaboration Tools:

Shared project tracker (e.g., Gantt or milestone format)
Regular check-ins via video or email
Secure file sharing of protocols, raw data, and reports

Your Role:

Provide input targets, background literature, and any prior assay experience
Approve design milestones (e.g., primer sites, specificity goals)
Supply any custom instrumentation requirements or samples (if applicable)

Ready to Screen Rare DNA Mutations?

Aegea Services Frequently Asked Questions (FAQs)

What products and services does Aegea offer?

Aegea provides a range of products and services, including research-use-only (RUO) kits, and custom assay development. These offerings are designed to integrate seamlessly into existing laboratory workflows, enhancing the sensitivity and specificity of molecular analyses.

Who can benefit from Aegea’s technologies?

Aegea’s solutions are tailored for a diverse clientele, including pharmaceutical and biotech companies, life science researchers, and clinical laboratories developing new technologies and assays for DNA mutation detection. Organizations seeking to improve the detection of rare genetic events or to develop multiplexed assays will find Aegea’s technologies particularly advantageous.

Does Aegea offer custom assay development?

Yes. Aegea collaborates with clients to develop custom assays and adapt its technologies to various platforms. This collaborative approach ensures that the assays meet specific research or clinical needs.

How can I initiate a collaboration with Aegea?

To explore collaboration opportunities, you can contact us here LINK. We welcome partnerships that aim to advance molecular diagnostics and personalized medicine.

What distinguishes Aegea from other life science companies?

Best-in-class Switch-Blocker technology is unmatched in analytic sensitivity for rare DNA mutation detection. The company owns a suite of nucleic acid amplification technologies and a robust portfolio of 11 issued U.S. patents, and a proven track record in clinical research and validation.